These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2874117)

  • 1. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in hepatic biotransformation in patients treated with beta-adrenergic drugs and prazosin].
    Adamska-Dyniewska H; Dziekański S
    Pol Tyg Lek; 1989 Apr 10-17; 44(15-16):361-3. PubMed ID: 2626354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF; Goldstein J; Zager PG; Sutton JM; Sirgo MA; Plachetka JR
    J Clin Hypertens; 1986 Sep; 2(3):285-93. PubMed ID: 2878065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of histamine H2 receptor blockers on hepatic elimination of drugs].
    Kettner W; Schröter U; Banditt P; Walther H
    Z Gesamte Inn Med; 1985 Feb; 40(4):96-8. PubMed ID: 4002755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of beta-adrenolytic drugs on hepatic clearance of antipyrine].
    Adamska-Dyniewska H; Pruszczyński J; Wichan P
    Pol Arch Med Wewn; 1984 Feb; 71(2):71-7. PubMed ID: 6146126
    [No Abstract]   [Full Text] [Related]  

  • 9. The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jun; 13(6):817-20. PubMed ID: 7093112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
    Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive actions of an isomer of labetalol and other vasodilator-beta-adrenoceptor blockers.
    Baum T; Sybertz EJ
    Fed Proc; 1983 Feb; 42(2):176-81. PubMed ID: 6130003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effects on renal function of 4 beta-blockers injected intravenously].
    Pozet N; Hadj Aissa AH; Labeeuw M; Zech P
    J Pharmacol; 1983; 14 Suppl 2():133-41. PubMed ID: 6138463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
    Pandhi P; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):297-300. PubMed ID: 2887519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.